Caris Life Sciences, Inc. cotiza a 29.53 USD y tiene una capitalización bursátil de $8.3B. En los últimos 12 meses ha facturado $990M con un margen de flujo de caja libre del 8.2%. Cotiza a 67.3 veces su flujo de caja libre (P/FCF) y a un PER de 79.4. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's mole…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | — | — | $0.28 |
| Estimado | $0.02 | $0.01 | $-0.02 | $0.10 |
| Sorpresa | — | — | — | +180.0% |
| Métrica | CAI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | 5.6% | -38.6% | +44.2% |
| Net Margin | -8.4% | -33.6% | +25.2% |
| FCF Margin | 8.2% | -13.9% | +22.1% |
| ROE | -11.8% | -40.4% | +28.6% |
| ROA | -6.0% | -32.0% | +26.0% |
| Current Ratio | 7.85 | 2.84 | +5.01 |
| Debt / Equity | 0.66 | 0.28 | +0.38 |